Completed PHASE3 INTERVENTIONAL 2-arm NCT02667444

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of Once Daily SB204 and Vehicle Gel in the Treatment of Acne Vulgaris

Sponsor: Chiltern International Inc.

Conditions Acne Vulgaris

Interventions SB204 4% Vehicle Gel

Updated 13 times since 2017 Last updated: Jul 12, 2023 Started: Feb 19, 2016 Primary completion: Dec 31, 2016 Completion: Dec 9, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Acne Vulgaris and is currently completed. Chiltern International Inc. leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

13 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Aug 2023 — Jul 2024 [monthly]

Completed PHASE3
Apr 2022 — Aug 2023 [monthly]

Completed PHASE3

▶ Show 8 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed PHASE3
Jun 2019 — Jan 2021 [monthly]

Completed PHASE3
Nov 2018 — Jun 2019 [monthly]

Completed PHASE3
Oct 2018 — Nov 2018 [monthly]

Completed PHASE3
Jun 2018 — Oct 2018 [monthly]

Completed PHASE3
Jan 2018 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Feb 2017 — Jan 2018 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chiltern International Inc.
Novan, Inc.

Data source: Novan, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Bay City, United States , Birmingham, United States , Boston, United States , Bradenton, United States , Broomall, United States , Bryan, United States , Cerritos, United States , Channelview, United States , Charlotte, United States and 42 more locations